Related Experiment Video
Updated: Jul 5, 2026

11:39
Identifying Cell Surface Markers of Primary Neural Stem and Progenitor Cells by Metabolic Labeling of Sialoglycan
Published on: September 7, 2019
Proteomics of neural stem cells.
Helena Skalnikova1, Petr Vodicka, Suresh Jivan Gadher
1Institute of Animal Physiology & Genetics, Academy of Sciences of the Czech Republic, Rumburska 89, 277 21 Libechov, Czech Republic. skalnikova@iapg.cas.cz
Expert Review of Proteomics
|May 10, 2008
Summary
Neural stem cell proteomics offers new therapeutic targets for neurological diseases. Understanding protein regulation in neural stem cell differentiation is key for regenerative medicine advancements.
Area of Science:
- Neuroscience
- Proteomics
- Regenerative Medicine
Background:
- Neural stem cells (NSCs) from mammalian CNS offer therapeutic potential for neurological disorders.
- Functional neurogenesis in adult CNS highlights NSC plasticity.
- Extensive molecular profiling of NSCs is ongoing to identify regulatory pathways.
Purpose of the Study:
- To review recent findings in neural stem cell proteomics.
- To discuss key proteins regulated during NSC differentiation.
- To explore the potential of these proteins in cell-based therapies.
Main Methods:
- Review of existing proteomic studies on primary and immortalized NSC and neural progenitor cell cultures.
- Analysis of proteins involved in differentiation from embryonic and mesenchymal stem cells.
- Synthesis of current knowledge on protein regulation in NSC differentiation.
Main Results:
- Proteomic studies have identified numerous proteins in neural stem cells and neural progenitors.
- Specific proteins are significantly regulated during the differentiation of neural stem cells into neurons and glial cells.
- Characterization of proteins from stem cell-derived neurons and glial cells is progressing.
Conclusions:
- Proteomics of neural stem cells is crucial for understanding self-renewal and differentiation.
- Identified regulatory proteins hold promise for future cell-based regenerative therapies for neurological diseases.
- Further proteomic investigations are needed to fully exploit NSC potential.

